Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases.
The principal finding from this study was the recognition that the α-adrenergic antagonist, phenoxybenzamine, possesses histone deacetylase inhibitory activity. Phenoxybenzamine is approved by the United States Food and Drug Administration for the treatment of hypertensive crises associated with tum...
Saved in:
Similar Items
-
Butyrate inhibits histone deacetylase 2 expression to alleviate liver fibrosis in biliary atresia
by: Yilin Zhao, et al.
Published: (2025-04-01) -
Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications
by: Saooda Ibrahim, et al.
Published: (2025-03-01) -
Profiling the Secretome of Glioblastoma Cells Under Histone Deacetylase Inhibition Using Mass Spectrometry
by: Aline Menezes, et al.
Published: (2025-02-01) -
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
by: Gustavo Salgado Pires, et al.
Published: (2025-04-01) -
Histone deacetylases: the critical enzymes for microglial activation involved in neuropathic pain
by: Yi Ding
Published: (2025-03-01)